Skip to main content

Table 1 Study population characteristics

From: [18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

Characteristics

Value

Age

Median 15.1 (7.4–19.7)

Sex

 

 Male

24/34 (70.6%)

 Female

10/34 (29.4%)

Histological variant

 Osteosarcoma

17/34 (50%)

 Ewing's sarcoma

13/34 (38.2%)

 Synovial sarcoma

2/34 (5.9%)

 Liver embryonal sarcoma

2/34 (5.9%)

Site

 Extremities

22/34 (64.8%)

 Scapula

2/34 (5.9%)

 Spine

1/34 (2.9%)

 Pelvis

2/34 (5.9%)

 Chest/abdominal

3/34 (8.8%)

 Lung

1/34 (2.9%)

 Liver

3/34 (8.8%)

AJCC

 IIa

11/34 (32.4%)

 IIb

16/34 (47.1%)

 III

1/34 (2.9%)

 IV

6/34 (17.6%)

Primary therapy

 Radical surgery

29/34 (85.3%)

 Radiation therapy

5/34 (14.7%)

  1. AJCC American Joint Commission on Cancer